http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0506761-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 2005-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d52f3ed351280e9b97c292bcbfa32a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4614955bb8a480b463637fda3a96d66b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d799bc17ff07140b9aa2a1f5d667a198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afabe4132e4fc910f8841120eca5000d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7003d62181c6868c825467a6d9db53e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d6778ab99d5424aad46718045a619ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7808e42cbc8a6446deba1ab45a9444e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be4a92bab913e8b38fa87509d9e333d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_163e5881cf7d68a85d3de2f9d3028421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c61747a5e8c1de26353be716c877ba7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6d1047965645fcbe90313841d590e32
publicationDate 2007-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0506761-A
titleOfInvention crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
abstract CRYSTALLINE POLYMORPH OF A BISULPHATE SALT OF A THROMBIN RECEPTOR ANTAGONIST. The present invention relates to a crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist compound which exhibits a powder X-ray diffraction profile substantially the same as that shown in Figure 1, or exhibits a profile differential scanning calorimetry, substantially the same as shown in Figure 3, and is represented by the formula for compound 2: Compound 2 the chemical formula should be entered here as it appears in the summary in paper form; and processes for preparing compound 2. Pharmaceutical compositions comprising the bisulfate salt polymorph and at least one excipient or carrier, and methods for using the polymorph of compound 2 for treating a variety of physiological disorders, such as thrombosis, are also described.
priorityDate 2004-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583499

Total number of triples: 58.